Literature DB >> 15127348

Unintended smallpox vaccination of HIV-1-infected individuals in the United States military.

Sybil A Tasker1, Glenn A Schnepf, Matthew Lim, Harold E Caraviello, Adam Armstrong, Mary Bavaro, Brian K Agan, Judith Delmar, Naomi Aronson, Mark R Wallace, John D Grabenstein.   

Abstract

We identified 10 individuals who had undiagnosed human immunodeficiency virus type 1 (HIV-1) infection at the time of smallpox vaccination. Mean CD4 cell count was 483 cells/mm3 (range, 286-751 cells/mm3), and mean log10 plasma HIV-1 RNA load was 4.13 copies/cm3 (range, 2.54-5.16 copies/cm3). All vaccinees (3 primary and 7 repeat) had a normal, robust reaction without complications. Smallpox vaccine was well-tolerated in this small series of HIV-1-infected military personnel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127348     DOI: 10.1086/420938

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.

Authors:  Ashraf S Ibrahim; Brad J Spellberg; Valentina Avenissian; Yue Fu; Scott G Filler; John E Edwards
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 2.  Development of a vaccine against Staphylococcus aureus.

Authors:  Brad Spellberg; Robert Daum
Journal:  Semin Immunopathol       Date:  2011-11-14       Impact factor: 9.623

Review 3.  An overview of vaccinations in HIV.

Authors:  Edgar Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2007-08       Impact factor: 5.495

Review 4.  Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.

Authors:  Nancy F Crum-Cianflone; Eva Sullivan
Journal:  Infect Dis Ther       Date:  2017-08-05

5.  Vaccination in patients with HIV infection.

Authors:  Todd D Gleeson; Mark R Wallace; Sybil A Tasker
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.663

6.  Progressive Vaccinia Acquired through Zoonotic Transmission in a Patient with HIV/AIDS, Colombia.

Authors:  Katherine Laiton-Donato; Paola Ávila-Robayo; Andrés Páez-Martinez; Paula Benjumea-Nieto; José A Usme-Ciro; Nicole Pinzón-Nariño; Ivan Giraldo; Diego Torres-Castellanos; Yoshinori Nakazawa; Nishi Patel; Kimberly Wilkins; Yu Li; Whitni Davidson; Jillybeth Burgado; Panayampalli Subbian Satheshkumar; Ashley Styczynski; Matthew R Mauldin; Martha Gracia-Romero; Brett W Petersen
Journal:  Emerg Infect Dis       Date:  2020-03       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.